CLTA Antikörper (Internal Region)
-
- Target Alle CLTA Antikörper anzeigen
- CLTA (Clathrin, Light Chain A (CLTA))
-
Bindungsspezifität
- Internal Region
-
Reaktivität
- Human
-
Wirt
- Ziege
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser CLTA Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC), ELISA
- Verwendungszweck
- CTLA + CTLB
- Sequenz
- CDFNPKSSKQ AKD
- Spezifität
- This antibody is expected to recognize all reported isoforms of light chains a and b.
- Kreuzreaktivität
- Rind (Kuh), Hund, Human, Maus, Ratte
- Aufreinigung
- Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
- Güteklasse
- Verified
- Immunogen
- Peptide with sequence CDFNPKSSKQAKD, from the internal region of the protein sequence according to NP_001824.1, NP_009027.1, NP_001070145.1, NP_001825.1, NP_009028.1.
- Isotyp
- IgG
- Top Product
- Discover our top product CLTA Primärantikörper
-
-
- Applikationshinweise
-
Immunohistochemistry: Paraffin embedded Human Spleen. Recommended concentration: 2.5 μg/mL.
Western Blot: Approx. 35 kDa and 22-23 kDa bands observed in Human Brain (Frontal Cortex) lysates (calculated MW of 23.2 kDa according to NP_001825.1). The observed molecular weight of ~35 kDa corresponds to earlier findings in literature with different anti
Peptide ELISA: antibody detection limit dilution 1:32000.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.5 mg/mL
- Buffer
- Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Minimize freezing and thawing.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.
-
- Target
- CLTA (Clathrin, Light Chain A (CLTA))
- Andere Bezeichnung
- CLTA (CLTA Produkte)
- Synonyme
- lca antikoerper, zgc:73358 antikoerper, wu:fb61d08 antikoerper, wu:fj48d06 antikoerper, CLTA antikoerper, DDBDRAFT_0169251 antikoerper, DDBDRAFT_0191305 antikoerper, DDB_0169251 antikoerper, DDB_0191305 antikoerper, clc antikoerper, LCA antikoerper, LCA1 antikoerper, LCA2 antikoerper, LCA3 antikoerper, CLTA2 antikoerper, AV026556 antikoerper, Clathrin light chain antikoerper, clathrin light chain A antikoerper, clathrin, light chain A antikoerper, clathrin, light chain (Lca) antikoerper, clathrin light chain antikoerper, clathrin, light polypeptide (Lca) antikoerper, clic-1 antikoerper, clta antikoerper, CLTA antikoerper, CNI00580 antikoerper, LOC5567495 antikoerper, CLC1 antikoerper, CpipJ_CPIJ018056 antikoerper, PTRG_01988 antikoerper, PMAA_096950 antikoerper, SJAG_04517 antikoerper, TSTA_044110 antikoerper, PAS_chr1-4_0158 antikoerper, clc antikoerper, Clta antikoerper
- Hintergrund
- CLTA, CTLB, clathrin, light chain (Lca), LCA, clathrin, light polypeptide (Lca), clathrin, light polypeptide A, clathrin, light chain (Lcb), LCB
- Gen-ID
- 1211, 1212, 12757
- NCBI Accession
- NP_001824, NP_009027, NP_001070145, NP_001825, NP_009028
- Pathways
- EGFR Signaling Pathway, Neurotrophin Signalübertragung, EGFR Downregulation
-